daratumumab,talquetamab,teclistamab
genmab,janssen
['talquetamab', 'redirectt-1', 'teclistamab', ' emd ']
promising results in the redirectt-1 trial combining teclistamab and talquetamab in r/r myeloma, including in pts w emd important to note 6 deaths (6.5%) from infection &amp; 52.7% grade 3/4 infections would be great to get more granular detail on these infections &amp; ppx #asco23 
haematology registrar | @harvardmed fellow @PORTAL_research | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer | SoMe Ed @BrJHaem